{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:25:26Z","timestamp":1789503926344,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijid.2025.108210","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T07:43:33Z","timestamp":1763538213000},"page":"108210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical and laboratory manifestations and outcomes of human parvovirus B19 infections in sickle cell anemia with emphasis on the impact of hydroxyurea"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6863-5748","authenticated-orcid":false,"given":"Salam","family":"Al kindi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema Mohamed","family":"Al-Riyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghadeer Al","family":"Naaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa Al","family":"Zadjali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil V.","family":"Pathare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108210_bib0001","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/791498","article-title":"Management of sickle cell disease: a review for physician education in Nigeria (sub-Saharan Africa)","volume":"2015","author":"Adewoyin","year":"2015","journal-title":"Anemia"},{"key":"10.1016\/j.ijid.2025.108210_bib0002","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/oxfordjournals.aje.a010288","article-title":"Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review","volume":"151","author":"Ashley-Koch","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2025.108210_bib0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1100\/tsw.2009.10","article-title":"Genetic etiologies for phenotypic diversity in sickle cell anemia","volume":"9","author":"Steinberg","year":"2009","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.ijid.2025.108210_bib0004","article-title":"Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease","volume":"9","author":"Knight-Madden","year":"2016","journal-title":"Cochrane Database Systemic Rev"},{"key":"10.1016\/j.ijid.2025.108210_bib0005","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.26719\/2001.7.6.1004","article-title":"A community-based study of common hereditary blood disorders in Oman","volume":"7","author":"Al-Riyami","year":"2001","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.ijid.2025.108210_bib0006","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/03630261003677213","article-title":"Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates","volume":"34","author":"Alkindi","year":"2010","journal-title":"Hemoglobin"},{"key":"10.1016\/j.ijid.2025.108210_bib0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2025.108210_bib0008","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-695X.2011.00819.x","article-title":"Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions","volume":"62","author":"Slavov","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijid.2025.108210_bib0009","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/1535370216636723","article-title":"Original Research: parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era","volume":"241","author":"Hankins","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.ijid.2025.108210_bib0010","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1172\/JCI111464","article-title":"Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia","volume":"74","author":"Platt","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2025.108210_bib0011","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.108210_bib0012","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1182\/blood-2012-03-419879","article-title":"Impact of hydroxyurea on clinical events in the BABY HUG trial","volume":"120","author":"Thornburg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2025.108210_bib0013","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2009.1.62","article-title":"Advances in the use of hydroxyurea","author":"Ware","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.ijid.2025.108210_bib0014","doi-asserted-by":"crossref","first-page":"425","DOI":"10.5001\/omj.2017.79","article-title":"Human parvovirus B19 in children with sickle cell disease; poking the spleen","volume":"32","author":"Saad","year":"2017","journal-title":"Oman Med J"},{"key":"10.1016\/j.ijid.2025.108210_bib0015","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1182\/blood.V86.2.776.bloodjournal862776","article-title":"Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease","volume":"86","author":"Gill","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2025.108210_bib0016","doi-asserted-by":"crossref","first-page":"O176","DOI":"10.1111\/1469-0691.12366","article-title":"Increased incidence of acute parvovirus B19 infections in Marseille, France, in 2012 compared with the 2002\u20132011 period","volume":"20","author":"Aherfi","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2025.108210_bib0017","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2003-01-0069","article-title":"Epidemiology of human parvovirus B19 in children with sickle cell disease","volume":"103","author":"Smith-Whitley","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ijid.2025.108210_bib0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2334-7-123","article-title":"Parvovirus B19 infection in Tunisian patients with sickle-cell anemia and acute erythroblastopenia","volume":"7","author":"Regaya","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108210_bib0019","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/pbc.22035","article-title":"Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease","volume":"53","author":"Yates","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijid.2025.108210_bib0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/infdis\/167.3.744","article-title":"Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence","volume":"167","author":"Foto","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108210_bib0021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/jcm.24.4.522-526.1986","article-title":"Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2025.108210_bib0022","first-page":"R104","article-title":"Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy?","volume":"4","author":"Gay","year":"1994","journal-title":"Commun Dis Rep CDR Rev"},{"key":"10.1016\/j.ijid.2025.108210_bib0023","first-page":"139","article-title":"A pilot study on the seroprevalence of parvovirus B19 infection","volume":"115","author":"Abraham","year":"2002","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.ijid.2025.108210_bib0024","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3855\/jidc.1807","article-title":"Molecular and serological assessment of parvovirus B19 infections among sickle cell anemia patients","volume":"5","author":"Obeid","year":"2011","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.ijid.2025.108210_bib0025","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2019.054","article-title":"Prevalence and factors associated with Human Parvovirus B19 infection in sickle cell patients hospitalized in Tanzania","volume":"11","author":"Urio","year":"2019","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.ijid.2025.108210_bib0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bjid.2012.06.026","article-title":"Molecular and clinical evaluation of the acute human parvovirus B19 infection: comparison of two cases in children with sickle cell disease and discussion of the literature","volume":"17","author":"Slavov","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijid.2025.108210_bib0027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<39::AID-AJH7>3.0.CO;2-#","article-title":"Genetic epidemiology of HbS in Oman: multicentric origin for the betaS gene","volume":"64","author":"Daar","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ijid.2025.108210_bib0028","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bcp.2017.03.022","article-title":"Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells","volume":"136","author":"Bonvicini","year":"2017","journal-title":"Biochem Pharmacol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225004321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:33:47Z","timestamp":1766406827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225004321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":28,"alternative-id":["S1201971225004321"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108210","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and laboratory manifestations and outcomes of human parvovirus B19 infections in sickle cell anemia with emphasis on the impact of hydroxyurea","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108210"}}